Therapeutic Areas: Dermatology | Oncology | Family Medicine

Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Incyte Corporation
Birmingham Alabama

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

UPDATED

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

UPDATED

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Birmingham Alabama 35243

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Birmingham Alabama

Patients are needed to participate in a clinical research study of Nivolumab + INCB24360

Mobile Alabama 36608

A clinical research study of talimogene laherparepvec, pembrolizumab (MK-3475) and placebo for the treatment of Melanoma, Unresected Melanoma

Mobile Alabama 36608

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Muscle Shoals Alabama 35661

Patients are needed to participate in a clinical research study to evaluate Melanoma

Arizona

Incyte Corporation
Scottsdale Arizona

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

UPDATED

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chandler Arizona 85224

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Goodyear Arizona 85338

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

Phoenix Arizona 85054

A clinical trial to evaluate treatments using HBI-8000 in combination with nivolumab for patients with Melanoma, Renal Cell Carcinoma or Non-Small Cell Lung Cancer

Phoenix Arizona 85054

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Phoenix Arizona 85054

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Phoenix Arizona 85018

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Phoenix Arizona 85032

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Scottsdale Arizona 85258

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona 85259

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona

A clinical trial to evaluate treatments using DCC-2618 for patients with Gastrointestinal Stromal Tumors, Aggressive Systemic Mastocytosis or Advanced Cancers

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

Tucson Arizona 85719

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Arkansas

Incyte Corporation
Little Rock Arkansas

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Fayetteville Arkansas 72703

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Fayetteville Arkansas 72703

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Hot Springs Arkansas 71913

Patients are needed to participate in a clinical research study to evaluate Melanoma

Hot Springs Arkansas 71913

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Little Rock Arkansas 72205

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

California

Incyte Corporation
Los Angeles California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
San Francisco California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
Santa Barbara California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
Santa Monica California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
Santa Monica California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

UPDATED

La Jolla California 92037-0845

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Orange California 92868

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

UPDATED

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab